Opportunity Overview
Throughout antiquity and the Middle Ages, Armenia was a key producer and exporter of pharmaceuticals, yet we know very little about the composition of these goods or the underlying medical system. We hypothesise that these treatments were of high quality, and therefore potentially of use for modern-day medicine.
Armenians and Greeks co-inhabited larger parts of Asia Minor, and since Greek medicine is relatively well researched, we are able to deploy a comparative approach between these two medical cultures rapidly and flexibly, which will allow us to identify valid treatments. We will consult Latin evidence, too.
Challenges: Any research on premodern medicine faces two main challenges, retrospective diagnosis and the identification of pharmaceuticals mentioned in premodern texts. We will use an interdisciplinary approach in which sciences (microbiology, genomics) inform humanities (manuscript studies, medical history) and vice versa to answer these questions.
Interdisciplinary research is often complicated by communication problems. We have been working together for three years and co- designed this proposal. Therefore, most of these matters have already been addressed. The PL has previously led a large, international collaboration between sciences and humanities, and we will draw on this experience (Wellcome Collaborative Award 217861/ Z/19/Z).
Aims and objectives: Our approach will lead to the creation of a new discipline, Premodern Medicine Studies, which will bridge the divide between sciences and humanities...
This is one of 44 active United Kingdom Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | UKRI CRCRM |
|---|---|
| Country | United Kingdom |
| Category | Pharmaceuticals |
| Published | December 31, 2025 |
| Procurement stage | Active solicitation |
| Response due | December 31, 2027 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Pharmaceuticals intelligence report in your inbox
A personalized report on United Kingdom Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.